Lorantis

Lorantis is a Health Care startup based in Cambridge, United Kingdom, with a focus on creating innovative solutions for targeting immunological and inflammatory diseases. Established in 1998, the company specializes in developing treatments for conditions such as allergies, asthma, autoimmune diseases, and transplant management. It has recently received a significant £25.00M Series C investment on 19 October 2005, with the participation of prominent investors including Abingworth, Apax Partners, Schroders, Quester Capital, Wellcome Trust, and JPMorgan Partners. Lorantis' dedication to advancing therapies in immunology positions it as a noteworthy player in the healthcare industry. With its promising solutions, the company presents an exciting opportunity for investors seeking to back pioneering initiatives in the field of targeted disease treatment.